[
    [
        {
            "time": "2018-03-28",
            "original_text": "Humana Inc. (HUM) Ex-Dividend Date Scheduled for March 28, 2018",
            "features": {
                "keywords": [
                    "Humana",
                    "Ex-Dividend",
                    "Date",
                    "Scheduled"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Humana Inc. (HUM) Ex-Dividend Date Scheduled for March 28, 2018",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 3,
                "Headline_Structure": 5,
                "Source_Recency": 2
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "Aetna to Pass on Drug Rebates to Consumers",
            "features": {
                "keywords": [
                    "Aetna",
                    "Drug",
                    "Rebates",
                    "Consumers"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Aetna to Pass on Drug Rebates to Consumers",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "UnitedHealthcare's Amil Receives Award for Improving Health Care Outcomes in Brazil",
            "features": {
                "keywords": [
                    "UnitedHealthcare",
                    "Amil",
                    "Award",
                    "Improving",
                    "Health",
                    "Care",
                    "Outcomes",
                    "Brazil"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "UnitedHealthcare's Amil Receives Award for Improving Health Care Outcomes in Brazil",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 2,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "Aetna to pass on drug rebates to some its members",
            "features": {
                "keywords": [
                    "Aetna",
                    "drug",
                    "rebates",
                    "members"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Aetna to pass on drug rebates to some its members",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "Aetna Will Pass Along Discounts as Drug Price Scrutiny Increases",
            "features": {
                "keywords": [
                    "Aetna",
                    "Discounts",
                    "Drug",
                    "Price",
                    "Scrutiny",
                    "Increases"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Aetna Will Pass Along Discounts as Drug Price Scrutiny Increases",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-28",
            "original_text": "Jim Cramer: A Hideous Day for Lots of Stocks",
            "features": {
                "keywords": [
                    "Jim",
                    "Cramer",
                    "Hideous",
                    "Day",
                    "Stocks"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "general"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Jim Cramer: A Hideous Day for Lots of Stocks",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        }
    ]
]